104 related articles for article (PubMed ID: 25247386)
1. N-glycoprotein analysis discovers new up-regulated glycoproteins in colorectal cancer tissue.
Nicastri A; Gaspari M; Sacco R; Elia L; Gabriele C; Romano R; Rizzuto A; Cuda G
J Proteome Res; 2014 Nov; 13(11):4932-41. PubMed ID: 25247386
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate.
Koshiyama A; Ichibangase T; Imai K
Biomed Chromatogr; 2013 Apr; 27(4):440-50. PubMed ID: 22991145
[TBL] [Abstract][Full Text] [Related]
3. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
[TBL] [Abstract][Full Text] [Related]
4. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
5. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
6. Stable isotope labeling of N-glycosylated peptides by enzymatic deglycosylation for mass spectrometry-based glycoproteomics.
Kaji H; Isobe T
Methods Mol Biol; 2013; 951():217-27. PubMed ID: 23296533
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of N-linked human glycoproteomic data sets reveals PTPRF ectodomain as a novel plasma biomarker candidate for prostate cancer.
Whitmore TE; Peterson A; Holzman T; Eastham A; Amon L; McIntosh M; Ozinsky A; Nelson PS; Martin DB
J Proteome Res; 2012 May; 11(5):2653-65. PubMed ID: 22494190
[TBL] [Abstract][Full Text] [Related]
8. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
[TBL] [Abstract][Full Text] [Related]
9. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.
Wu J; Xie X; Liu Y; He J; Benitez R; Buckanovich RJ; Lubman DM
J Proteome Res; 2012 Sep; 11(9):4541-52. PubMed ID: 22827608
[TBL] [Abstract][Full Text] [Related]
10. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
11. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C
J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327
[TBL] [Abstract][Full Text] [Related]
12. Targeted quantitative mass spectrometric identification of differentially expressed proteins between Bax-expressing and deficient colorectal carcinoma cells.
Wang P; Lo A; Young JB; Song JH; Lai R; Kneteman NM; Hao C; Li L
J Proteome Res; 2009 Jul; 8(7):3403-14. PubMed ID: 19425606
[TBL] [Abstract][Full Text] [Related]
13. Proteomic methodologies and their application in colorectal cancer research.
Ikonomou G; Samiotaki M; Panayotou G
Crit Rev Clin Lab Sci; 2009; 46(5-6):319-42. PubMed ID: 19958217
[TBL] [Abstract][Full Text] [Related]
14. Chemical methods for glycoprotein discovery.
Bond MR; Kohler JJ
Curr Opin Chem Biol; 2007 Feb; 11(1):52-8. PubMed ID: 17174139
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic 18O-labeling strategies for quantitative proteomics.
Miyagi M; Rao KC
Mass Spectrom Rev; 2007; 26(1):121-36. PubMed ID: 17086517
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin.
Xing X; Lai M; Gartner W; Xu E; Huang Q; Li H; Chen G
Proteomics; 2006 May; 6(9):2916-23. PubMed ID: 16586428
[TBL] [Abstract][Full Text] [Related]
17.
Pirro M; Mohammed Y; van Vliet SJ; Rombouts Y; Sciacca A; de Ru AH; Janssen GMC; Tjokrodirijo RTN; Wuhrer M; van Veelen PA; Hensbergen PJ
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752259
[TBL] [Abstract][Full Text] [Related]
18. Identification of HnRNP M as a novel biomarker for colorectal carcinoma by quantitative proteomics.
Chen S; Zhang J; Duan L; Zhang Y; Li C; Liu D; Ouyang C; Lu F; Liu X
Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(5):G394-403. PubMed ID: 24381081
[TBL] [Abstract][Full Text] [Related]
19. Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profiling.
Melle C; Bogumil R; Ernst G; Schimmel B; Bleul A; von Eggeling F
Proteomics; 2006 Apr; 6(8):2600-8. PubMed ID: 16502466
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric identification of N-linked glycopeptides using lectin-mediated affinity capture and glycosylation site-specific stable isotope tagging.
Kaji H; Yamauchi Y; Takahashi N; Isobe T
Nat Protoc; 2006; 1(6):3019-27. PubMed ID: 17406563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
